BRCA1 is a new MITF target gene

Pigment Cell and Melanoma Research

Volumn 24, Issue 4, 2011, Pages 725-727

  Beuret, Laurent ^a,b   Ohanna, Mickael ^a,b   Strub, Thomas ^c   Allegra, Maryline ^a,b   Davidson, Irwin ^c   Bertolotto, Corine ^a,b,d   Ballotti, Robert ^a,b,d  

^a CENTRE MÉDITERRANÉEN DE MÉDECINE MOLÉCULAIRE C3M   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; SMALL INTERFERING RNA;

DNA DAMAGE; DNA REPAIR; GENE TARGETING; GENOMIC INSTABILITY; HUMAN; LETTER; MELANOCYTE; MELANOMA CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ULTRAVIOLET RADIATION; WESTERN BLOTTING;

ANIMALS; BRCA1 PROTEIN; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; GENE SILENCING; HISTONES; HUMANS; MELANOMA; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; SKIN NEOPLASMS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 80051885153     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2011.00862.x     Document Type: Letter

References (8)

1. Carreira, S., Goodall, J., Denat, L., Rodriguez, M., Nuciforo, P., Hoek, K.S., Testori, A., Larue, L., and Goding, C.R. (2006). Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev. 20, 3426-3439.
2. Cheli, Y., Giuliano, S., Botton, T., Rocchi, S., Hofman, V., Hofman, P., Bahadoran, P., Bertolotto, C., and Ballotti, R. (2011). MITF is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene, doi: 10.1038/onc.2010.598.
3. Garraway, L.A., Widlund, H.R., Rubin, M.A. et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117-122.
4. Giuliano, S., Cheli, Y., Ohanna, M. et al. (2010). Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas. Cancer Res. 70, 3813-3822.
5. Gottifredi, V., Karni-Schmidt, O., Shieh, S.S., and Prives, C. (2001). p53 down-regulates CHK1 through p21 and the retinoblastoma protein. Mol. Cell. Biol. 21, 1066-1076.
6. Kauffmann, A., Rosselli, F., Lazar, V., Winnepenninckx, V., Mansuet-Lupo, A., Dessen, P., Van Den Oord, J.J., Spatz, A., and Sarasin, A. (2008). High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene 27, 565-573.
7. Strub, T., Giuliano, S., Ye, T. et al. (2011). Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene, doi: 10.1038/onc.2010.612.
8. Winnepenninckx, V., Lazar, V., Michiels, S. et al. (2006). Gene expression profiling of primary cutaneous melanoma and clinical outcome. J. Natl Cancer Inst. 98, 472-482.